Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
189 INR | -1.72% | +0.59% | +17.50% |
Jul. 02 | Marksans Pharma Gets UK Regulator's Nod for Two Products | MT |
May. 31 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 |
Sales 2024 | 21.77B 261M | Sales 2025 * | 26.7B 320M | Capitalization | 85.72B 1.03B |
---|---|---|---|---|---|
Net income 2024 | 3.14B 37.56M | Net income 2025 * | 3.97B 47.48M | EV / Sales 2024 | 3.16 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.21 x |
P/E ratio 2024 |
22
x | P/E ratio 2025 * |
21.5
x | Employees | 852 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.97% |
Latest transcript on Marksans Pharma Limited
1 day | -1.72% | ||
1 week | +0.59% | ||
Current month | +18.98% | ||
1 month | +18.98% | ||
3 months | +15.99% | ||
6 months | +15.88% | ||
Current year | +17.50% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 92-04-15 | |
Director of Finance/CFO | 55 | 02-09-05 | |
Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sunny Sharma
BRD | Director/Board Member | 49 | 21-08-10 |
Chief Executive Officer | 52 | 92-04-15 | |
Director/Board Member | 52 | 14-09-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 189 | -1.72% | 69,444 |
24-07-11 | 192.3 | +2.29% | 242,188 |
24-07-10 | 188 | +0.62% | 288,065 |
24-07-09 | 186.8 | -1.03% | 88,695 |
24-07-08 | 188.8 | +0.48% | 305,673 |
Delayed Quote Bombay S.E., July 12, 2024 at 06:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- MARKSANS Stock
- MARKSANS Stock